Microbial Metabolism

Fundamentals of Microbial Metabolism

• Metabolic Organization and Cellular Imperatives:

  • All microbial cells must accomplish two primary, interconnected tasks to survive and propagate:
  • Synthesizing new biological components, including cell walls, cell membranes, ribosomes, and nucleic acids.
  • Harvesting and transducing chemical energy to drive thermodynamic non-spontaneous reactions.
  • Metabolism: The sum total of all chemical reactions occurring within a living organism.
  • Human Implications and Practical Applications:
  • Microbial metabolism is harnessed industrial-scale to produce biofuels (e.g., ethanol, butanol).
  • It underpins modern food and beverage production (e.g., yogurt, cheese, pickles, wine, beer, bread).
  • Serves as foundational models for biochemical and genetic laboratory research.
  • Unique microbial metabolic pathways furnish critical targets for selective antibacterial and antifungal drug therapies.

• Division of Metabolism into Catabolism and Anabolism:

  • Catabolism:
  • The set of metabolic pathways that break down complex organic compounds into simpler end products.
  • Exergonic processes that harvest released energy to produce adenosine triphosphate ($\text{ATP}$).
  • Concurrently generates essential precursor metabolites required as carbon skeletons for subsequent biosynthesis.
  • Anabolism (Biosynthesis):
  • The set of metabolic pathways that assemble simple subunits (amino acids, nucleotides, monosaccharides, fatty acids) into macromolecules (proteins, nucleic acids, polysaccharides, complex lipids) and cellular structures.
  • Endergonic processes that utilize the chemical energy stored in $\text{ATP}$ and carbon backbones provided by precursor metabolites.
  • Interdependence: Catabolism and anabolism are tightly coupled; catabolism releases energy and generates $\text{ATP}$, whereas anabolism consumes energy and hydrolyzes $\text{ATP}$ to $\text{ADP} + \text{P}_i$.

• Architecture of Metabolic Pathways:

  • Metabolic pathways consist of organized sequences of enzyme-catalyzed chemical reactions converting a starting compound into one or more final end products.
  • Pathways generally adopt three configurations:
  • Linear Metabolic Pathway: A sequence where the starting compound progresses sequentially through intermediates ($\text{Intermediate}_a \rightarrow \text{Intermediate}_b$) to a single end product.
  • Branched Metabolic Pathway: A pathway where an intermediate diverges into two separate branches, yielding distinct end products ($\text{End product}_1$ and $\text{End product}_2$).
  • Cyclical Metabolic Pathway: A circular sequence where an intermediate regenerates the starting compound of the cycle while releasing metabolic products or generating reducing power (e.g., the tricarboxylic acid cycle).

Enzymes and Biochemical Energetics

• Enzymatic Catalysis and Activation Energy:
  • Enzymes: Biological catalysts composed predominantly of proteins that dramatically accelerate the rate of cellular chemical reactions without being consumed or permanently altered.
  • Enzyme nomenclature reflects biological function, systematically concluding with the suffix -ase.
  • Activation Energy ($E_a$): The initial energy threshold required to destabilize chemical bonds and initiate a reaction.
  • Enzymes do not alter the overall free energy change ($\Delta G$) of a reaction; instead, they lower the $E_a$, allowing reactions to proceed rapidly under cellular physiological conditions.

• Active Site and Induced Fit Mechanism:
  • Active Site: A specialized pocket or crevice on the enzyme where specific substrates bind with high specificity via weak, non-covalent interactions.
  • Binding causes a conformational shift in the enzyme's three-dimensional structure (induced fit), exerting physical and electronic strain that destabilizes existing covalent bonds and facilitates the formation of new chemical bonds.
  • Upon catalysis, the enzyme-substrate complex disassembles, discharging products and returning the active site to its original conformation for subsequent catalytic cycles.

• The High-Energy Phosphate Bond and ATP:

  • Adenosine Triphosphate ($\text{ATP}$): The universal metabolic energy currency of living cells.
  • Consists of an adenosine molecule attached to a chain of three negatively charged phosphate groups separated by high-energy phosphoanhydride bonds.
  • Energy Coupling:
  • Energy harvested from exergonic catabolic reactions drives the phosphorylation of adenosine diphosphate ($\text{ADP}$) and inorganic phosphate ($\text{P}_i$) into $\text{ATP}$:       $\text{ADP} + \text{P}_i + \text{Energy} \rightarrow \text{ATP}$
  • Hydrolysis of the terminal phosphoanhydride bond releases free energy ($\sim 30.5\,kJ\,mol^{-1}$ under standard biological conditions) to power endergonic anabolic work:       $\text{ATP} \rightarrow \text{ADP} + \text{P}_i + \text{Energy}$

• Redox Reactions and Electron Transfer Principles:

  • Metabolic energy generation relies upon oxidation-reduction (redox) reactions involving the transfer of electrons from a donor to an acceptor.
  • Oxidation: The removal or loss of electrons from a compound (the electron donor acts as the reducing agent).
  • Reduction: The addition or gain of electrons by a compound (the electron acceptor acts as the oxidizing agent).
  • In biological dehydrogenation reactions, an electron is transferred together with a proton, effectively moving a whole hydrogen atom ($\text{H} = \text{e}^- + \text{H}^+$).
  • The total quantity of free energy released is directly proportional to the difference in electron affinity (electronegativity) between the chemical energy source (electron donor) and the terminal electron acceptor.
  • Prokaryotes demonstrate diverse capabilities, utilizing either organic compounds (e.g., glucose) or inorganic compounds (e.g., $\text{H}_2$, $\text{H}_2\text{S}$, $\text{Fe}^{2+}$) as electron donors, and employing oxygen ($\text{O}_2$) or inorganic ions ($\text{NO}_3^-$, $\text{SO}_4^{2-}$, $\text{CO}_2$) as terminal electron acceptors.

• Soluble Electron Carriers and Reducing Power:
  • Cells extract energy sequentially in gradual steps, transferring released electrons to specific soluble electron carriers that function as transient reservoirs of reducing power.
  • The three primary physiological electron carriers include:
  • Nicotinamide Adenine Dinucleotide ($\text{NAD}^+/\text{NADH}$): Carries $2\,e^-$ and $1\,\text{H}^+$. Reversible reaction: $\text{NAD}^+ + 2\,\text{e}^- + 2\,\text{H}^+ \rightleftharpoons \text{NADH} + \text{H}^+$. The electrons carried are used in the electron transport chain to generate proton motive force for $\text{ATP}$ synthesis.
  • Flavin Adenine Dinucleotide ($\text{FAD}/\text{FADH}_2$): Carries $2\,e^-$ and $2\,\text{H}^+$ (two hydrogen atoms). Reversible reaction: $\text{FAD} + 2\,\text{e}^- + 2\,\text{H}^+ \rightleftharpoons \text{FADH}_2$. Transports electrons into the electron transport chain to generate proton motive force.
  • Nicotinamide Adenine Dinucleotide Phosphate ($\text{NADP}^+/\text{NADPH}$): Carries $2\,e^-$ and $1\,\text{H}^+$. Reversible reaction: $\text{NADP}^+ + 2\,\text{e}^- + 2\,\text{H}^+ \rightleftharpoons \text{NADPH} + \text{H}^+$. Its reducing power is dedicated almost exclusively to anabolic biosynthetic pathways.

Central Metabolic Pathways: Glycolysis, Transition Step, and the TCA Cycle

• Glycolysis (Embden-Meyerhof-Parnas Pathway):

  • Primary pathway oxidizing $1$ molecule of glucose ($6\text{C}$) into $2$ molecules of pyruvate ($3\text{C}$) through a sequential 10-step enzymatic series in the cytoplasm.
  • Operates in both the presence and absence of molecular oxygen ($\text{O}_2$).
  • Investment Phase (Preparatory Steps):
  • Step 1: Phosphorylation of glucose by hexokinase/glucokinase consumes $1\,\text{ATP}$, yielding glucose-6-phosphate.
  • Step 2: Isomerization to fructose-6-phosphate.
  • Step 3: Phosphorylation of fructose-6-phosphate by phosphofructokinase consumes a second $1\,\text{ATP}$, yielding fructose-1,6-bisphosphate.
  • Step 4: Cleavage of fructose-1,6-bisphosphate into two interconvertible $3\text{C}$ isomers: glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP).
  • Step 5: Rapid isomerization of DHAP into G3P; all subsequent steps occur twice per initial glucose.
  • Payoff Phase (Energy Generation Steps):
  • Step 6: Oxidation and phosphorylation of G3P coupled to the reduction of $\text{NAD}^+ \rightarrow \text{NADH} + \text{H}^+$, yielding high-energy 1,3-bisphosphoglycerate.
  • Step 7: Substrate-level phosphorylation transfers a high-energy phosphate group to $\text{ADP}$, producing $1\,\text{ATP}$ per $3\text{C}$ unit ($2\,\text{ATP}$ total) and 3-phosphoglycerate.
  • Step 8: Chemical rearrangement yields 2-phosphoglycerate.
  • Step 9: Dehydration removes $\text{H}_2\text{O}$, producing phosphoenolpyruvate (PEP) containing an unstable high-energy phosphate bond.
  • Step 10: Second substrate-level phosphorylation transfers the phosphate from PEP to $\text{ADP}$, yielding $1\,\text{ATP}$ per $3\text{C}$ unit ($2\,\text{ATP}$ total) and pyruvate.
  • Net Balance of Glycolysis per Glucose Molecule:
  • Net ATP: $2\,\text{ATP}$ ($4\,\text{ATP}$ generated $- 2\,\text{ATP}$ invested) via substrate-level phosphorylation.
  • Reducing Power: $2\,\text{NADH} + 2\,\text{H}^+$.
  • Products: $2$ pyruvate molecules, precursor metabolites for biosynthesis.

• The Pentose Phosphate Pathway:

  • Serves as an alternative glucose oxidation route dedicated to generating reducing power in the form of $\text{NADPH}$ and essential metabolic intermediates.
  • Produces ribose-5-phosphate (necessary for nucleotide biosynthesis) and erythrose-4-phosphate (used for aromatic amino acid synthesis).

• The Transition Step (Pyruvate Decarboxylation):

  • Links glycolysis to the tricarboxylic acid (TCA) cycle by converting the $3\text{C}$ pyruvate into a $2\text{C}$ acetyl group attached to coenzyme A.
  • Operates twice per glucose molecule:     $\text{Pyruvate} + \text{NAD}^+ + \text{CoA} \rightarrow \text{Acetyl-CoA} + \text{NADH} + \text{H}^+ + \text{CO}_2$
  • Yield per glucose ($2$ pyruvates): $2\,\text{NADH} + 2\,\text{H}^+$, $2\,\text{CO}_2$, and $2$ acetyl-CoA.

• The Tricarboxylic Acid (TCA / Krebs / Citric Acid) Cycle:

  • A cyclical metabolic pathway in the prokaryotic cytoplasm (mitochondrial matrix in eukaryotes) that completes the total oxidation of carbon skeletons.
  • Cyclical Sequence (per turn of the cycle):
  • Acetyl group ($2\text{C}$) from acetyl-CoA is transferred to oxaloacetate ($4\text{C}$) to form citrate ($6\text{C}$), regenerating free CoA.
  • Citrate is isomerized to isocitrate.
  • Isocitrate is oxidized to $\alpha$-ketoglutarate ($5\text{C}$), reducing $\text{NAD}^+ \rightarrow \text{NADH} + \text{H}^+$ and releasing $1\,\text{CO}_2$.
  • $\alpha$-Ketoglutarate undergoes oxidative decarboxylation and attaches CoA to form succinyl-CoA ($4\text{C}$), reducing $\text{NAD}^+ \rightarrow \text{NADH} + \text{H}^+$ and releasing $1\,\text{CO}_2$.
  • Removal of CoA from succinyl-CoA releases energy harvested to drive substrate-level phosphorylation, generating $1\,\text{ATP}$ (or $\text{GTP}$) and succinate.
  • Succinate is oxidized to fumarate, reducing $\text{FAD} \rightarrow \text{FADH}_2$.
  • Fumarate is hydrated to malate.
  • Malate is oxidized to oxaloacetate, reducing $\text{NAD}^+ \rightarrow \text{NADH} + \text{H}^+$, thereby regenerating oxaloacetate for another cycle.
  • Net Yield of the TCA Cycle:
  • Per single turn ($1$ acetyl-CoA): $3\,\text{NADH} + 3\,\text{H}^+$, $1\,\text{FADH}_2$, $1\,\text{ATP}$, and $2\,\text{CO}_2$.
  • Per glucose molecule ($2$ turns of the cycle): $6\,\text{NADH} + 6\,\text{H}^+$, $2\,\text{FADH}_2$, $2\,\text{ATP}$, and $4\,\text{CO}_2$.

Respiration and Chemiosmotic ATP Generation

• Chemiosmotic Hypothesis and Peter Mitchell:

  • Proposed by British biochemist Peter Mitchell in 1961.
  • Initially met with widespread skepticism; Mitchell validated the model through independent, self-funded experimental investigations.
  • Mitchell was awarded the Nobel Prize in Chemistry in 1978 for establishing the chemiosmotic theory.
  • Explains that energy released from oxidation of metabolic fuels is not coupled to phosphorylation through chemical intermediates, but through the establishment of an electrochemical proton gradient across an energy-transducing membrane.

• Prokaryotic Electron Transport Chain (ETC):

  • Composed of a series of membrane-embedded protein complexes and mobile lipid-soluble carriers embedded directly within the prokaryotic cytoplasmic membrane (mitochondrial inner membrane in eukaryotes).
  • Electron Transfer Cascade:
  • Electrons harvested from $\text{NADH}$ enter Complex I (NADH dehydrogenase) and transfer to ubiquinone, while electrons from $\text{FADH}_2$ enter through Complex II (succinate dehydrogenase).
  • Electrons traverse sequential electron carriers of increasing redox potential (e.g., cytochromes, iron-sulfur proteins, ubiquinol oxidase), gradually shedding free energy.
  • In aerobic respiration, the terminal electron acceptor is molecular oxygen ($\text{O}_2$), which is reduced to water:       $\frac{1}{2}\text{O}_2 + 2\,\text{e}^- + 2\,\text{H}^+ \rightarrow \text{H}_2\text{O}$
  • Generation of the Proton Motive Force (PMF):
  • As electrons traverse the chain, specific complexes act as proton pumps, translocating protons ($\text{H}^+$) from the cytoplasm across the cytoplasmic membrane to the exterior.
  • Establishes a transmembrane electrochemical gradient with an excess of protons and positive charge on the exterior relative to the interior.

• Cellular Work Driven by the Proton Motive Force:
  • Oxidative Phosphorylation via ATP Synthase:
  • Protons flow down their electrochemical gradient back into the cytoplasm exclusively through the catalytic channel of the enzyme ATP synthase.
  • The proton flux induces mechanical rotation of the enzyme's stalk and catalytic head, driving the conformational changes that phosphorylate $\text{ADP} + \text{P}_i \rightarrow \text{ATP}$.
  • Bacterial Flagellar Motility: Direct entry of protons through basal body stator complexes powers the mechanical rotation of flagellar filaments.
  • Active Transport: Specific transport proteins exploit the downhill movement of protons into the cell to couple the symport or antiport of nutrients and toxic metabolites against concentration gradients.

Fermentation Pathways and Industrial Significance

• Respiration versus Fermentation Dynamics:
  • When cells possess an electron transport chain and suitable terminal electron acceptors, they utilize respiration to optimize $\text{ATP}$ yields.
  • Aerobic Respiration: Employs $\text{O}_2$ as the terminal electron acceptor, delivering a theoretical maximum yield of $36\text{--}38\,\text{ATP}$ per glucose.
  • Anaerobic Respiration: Employs alternative inorganic terminal electron acceptors ($\text{SO}_4^{2-}$, $\text{NO}_3^-$, $\text{CO}_3^{2-}$), delivering lower yields ($2\text{--}36\,\text{ATP}$) depending on the redox potential of the terminal acceptor.
  • Fermentation: Employed when acceptable terminal electron acceptors are exhausted or in microorganisms that lack an electron transport chain entirely (e.g., Streptococcus pneumoniae).

• Biochemical Mechanics of Fermentation:

  • Fermentation generates no additional ATP beyond the net $2\,\text{ATP}$ produced in glycolysis via substrate-level phosphorylation.
  • The essential biochemical purpose of fermentation is the re-oxidation of $\text{NADH} + \text{H}^+$ back to $\text{NAD}^+$, ensuring a sustained pool of electron acceptors so glycolysis can continue running.
  • Pyruvate or an organic derivative acts as the terminal electron acceptor.
  • Organisms vary in capability:
  • Escherichia coli is a facultative anaerobe capable of aerobic respiration, anaerobic respiration, and fermentation.
  • Streptococcus pneumoniae lacks an electron transport chain and is obligately dependent upon fermentation.

• Diversity of Fermentation Pathways and Commercial Products:

  • Lactic Acid Fermentation:
  • Pyruvate directly accepts electrons from $\text{NADH}$, producing lactic acid (lactate):       $\text{Pyruvate} + \text{NADH} + \text{H}^+ \rightarrow \text{Lactate} + \text{NAD}^+$
  • Conducted by Streptococcus and Lactobacillus.
  • Utilized in the commercial manufacture of yogurt, cheeses, sour cream, and fermented pickles.
  • Ethanol Fermentation:
  • Pyruvate is decarboxylated to acetaldehyde (releasing $\text{CO}_2$), which is subsequently reduced by $\text{NADH}$ to ethanol:       $\text{Pyruvate} \rightarrow \text{Acetaldehyde} + \text{CO}_2$$\text{Acetaldehyde} + \text{NADH} + \text{H}^+ \rightarrow \text{Ethanol} + \text{NAD}^+$
  • Conducted by yeasts such as Saccharomyces cerevisiae.
  • Produces alcoholic beverages (wine, beer) and bread dough leavening.
  • Butyric Acid Fermentation:
  • Complex branched pathway producing butyric acid, butanol, acetone, isopropanol, $\text{CO}_2$, and $\text{H}_2$.
  • Conducted by obligate anaerobes of the genus Clostridium.
  • Propionic Acid Fermentation:
  • Converts pyruvate and lactate into propionic acid, acetic acid, and $\text{CO}_2$.
  • Conducted by Propionibacterium species.
  • Imparts the characteristic nutty flavor (propionic acid) and gas holes/eyes ($\text{CO}_2$ gas bubbles) to Swiss cheese.
  • Mixed Acid Fermentation:
  • Produces a complex mixture of lactic acid, acetic acid, succinic acid, formic acid, ethanol, $\text{CO}_2$, and $\text{H}_2$.
  • Conducted by members of the family Enterobacteriaceae (e.g., Escherichia coli).
  • Identified clinically by the Methyl-Red (MR) test, which detects a deep drop in pH resulting from mixed acid accumulation.
  • 2,3-Butanediol Fermentation:
  • Converts pyruvate through acetoin to 2,3-butanediol and $\text{CO}_2$.
  • Characteristic of Enterobacter species.
  • Identified clinically by the Voges-Proskauer (VP) test, which detects the precursor neutral metabolite acetoin.

Bacterial Genome Organization and DNA Replication

• Genome Structure and the Central Dogma:

  • Genome: The complete complement of genetic information carried by an organism, encompassing the bacterial chromosome and any autonomous plasmids.
  • All cellular organisms possess a genome constructed from deoxyribonucleic acid (DNA).
  • Gene: The fundamental functional physical unit of heredity, encoding a functional transcript (messenger RNA, transfer RNA, or ribosomal RNA), typically translated into a protein.
  • Genomics: The comprehensive scientific study and sequence mapping of nucleotide orders in genomes.
  • Central Dogma of Molecular Biology: Directional flow of genetic information: DNA is replicated to preserve information, transcribed into RNA, and translated into functional protein polymers ($\text{DNA} \rightarrow \text{RNA} \rightarrow \text{Protein}$).

• Biochemical Architecture of Double-Stranded DNA:

  • DNA is configured as a double-stranded, right-handed antiparallel helix.
  • Each individual strand consists of deoxynucleotide units joined via covalent phosphodiester bonds between the $5'$ phosphate group of one nucleotide and the $3'$ hydroxyl group ($-\text{OH}$) of the adjacent pentose deoxyribose sugar.
  • Antiparallel Alignment: One strand runs in the $5' \rightarrow 3'$ orientation, while the complementary opposite strand runs in the $3' \rightarrow 5'$ orientation.
  • Complementary Base Pairing:
  • Strands are held together by interior hydrogen bonds formed between complementary nitrogenous nucleobases:
    • Adenine (A) pairs with Thymine (T) via $2$ hydrogen bonds.
    • Guanine (G) pairs with Cytosine (C) via $3$ hydrogen bonds.
  • Denaturation or "melting" refers to the separation of double-stranded DNA into two single strands through breaking of these hydrogen bonds (induced by thermal agitation or basic pH).

• Bidirectional, Semiconservative Replication Mechanics:

  • Semiconservative Mode: Following replication, each newly formed double-stranded daughter DNA molecule comprises one conserved parental template strand and one newly synthesized complementary strand.
  • Origin of Replication (oriC): A specific nucleotide sequence recognized by initiator proteins that bind, destabilize, and melt the duplex DNA.
  • Bidirectional Replication Forks: DNA synthesis proceeds simultaneously in both directions from the origin, establishing two advancing replication forks that travel around the circular chromosome until meeting at the terminating site (terminus).

• The Replication Machinery and Enzymology:
  • Replisome: The immense, coordinated multi-protein enzymatic complex assembled at the replication fork that synthesizes DNA.
  • Components of Bacterial DNA Replication (Table 7.1):
  • Replisome: The complex of enzymes and other proteins that synthesize DNA.
  • DNA gyrase: Enzyme that temporarily breaks the strands of DNA, relieving the mechanical torsional strain caused by unwinding the two strands of the DNA helix ahead of the fork.
  • DNA ligase: Enzyme that joins two adjacent DNA fragments by catalyzing a covalent phosphodiester bond between the $3'$ hydroxyl and $5'$ phosphate residues of adjacent nucleotides.
  • DNA polymerases: Enzymes that synthesize DNA; they use one strand of DNA as a template to make the complementary strand. Nucleotides can be added only to the $3'$ end of an existing strand; therefore, synthesis always occurs in the $5' \rightarrow 3'$ direction.
  • Helicases: Enzymes that unwind and separate the DNA double helix ahead of the advancing replication fork.
  • Okazaki fragment: Nucleic acid fragment produced during the discontinuous synthesis of the lagging strand of DNA.
  • Origin of replication: Distinct region of a DNA molecule at which replication is initiated.
  • Primase: Enzyme that synthesizes short stretches of RNA (primers) complementary to the DNA template to provide a free $3'-\text{OH}$ for DNA polymerase.
  • Primer: Fragment of nucleic acid to which DNA polymerase can add nucleotides, as DNA polymerases cannot initiate synthesis de novo.
  • Leading versus Lagging Strand Synthesis:
  • Leading Strand: Synthesized continuously into the replication fork in the $5' \rightarrow 3'$ direction.
  • Lagging Strand: Synthesized discontinuously away from the replication fork, generating short Okazaki fragments.
  • Each Okazaki fragment requires a distinct RNA primer synthesized by primase. DNA polymerase extends the fragment until encountering the $5'$ end of the previous fragment.
  • A different DNA polymerase excises the RNA primer nucleotides and replaces them with deoxynucleotides, and DNA ligase seals the nick by forming a covalent bond.
  • Replication Kinetics:
  • Complete replication of the E. coli chromosome requires approximately $40\text{ minutes}$.
  • In nutrient-rich environments, E. coli displays an optimal generation doubling time of approximately $20\text{ minutes}$.
  • Cells resolve this kinetic disparity by initiating a new round of bidirectional chromosome replication before the previous round has terminated; daughter cells inherit chromosomes that are already partially duplicated.

Bacterial Transcription and Gene Expression Mechanisms

• The Transcription Process:

  • The synthesis of a single-stranded RNA transcript from a DNA template catalyzed by the enzyme RNA polymerase.
  • RNA polymerase synthesizes transcripts exclusively in the $5' \rightarrow 3'$ direction using ribonucleoside triphosphates (ATP, UTP, GTP, CTP).
  • Unlike DNA polymerases, RNA polymerase can initiate synthesis de novo without requiring a pre-existing primer.
  • RNA polymerase binds upstream at a promoter sequence and ceases transcription upon reaching a terminator sequence.

• Transcriptional Polarity and Strand Nomenclature:

  • Minus ($-$) Strand (Template Strand): The specific strand of the DNA double helix that serves as the physical template for RNA synthesis; the resulting RNA transcript is antiparallel and complementary to this strand.
  • Plus ($+$) Strand (Coding Strand): The DNA strand complementary to the minus template strand; possesses the identical nucleotide sequence as the synthesized RNA molecule, with thymine (T) in DNA substituted by uracil (U) in RNA.
  • Promoters orient the physical directionality of RNA polymerase binding, which dictates which of the two strands functions as the minus template for that specific transcription unit.

• Bacterial Transcription Factors and Stages (Table 7.2):

  • Components of Bacterial Transcription:
  • ($-$) strand: Strand of DNA that serves as the template for RNA synthesis; the resulting RNA molecule is complementary to this strand.
  • ($+$) strand: Strand of DNA complementary to the one that serves as the template for RNA synthesis; the nucleotide sequence of the RNA molecule is the same as this strand, except it has uracil rather than thymine.
  • Promoter: Specific nucleotide sequence to which RNA polymerase binds to initiate transcription.
  • RNA polymerase: Enzyme that synthesizes RNA using single-stranded DNA as a template; synthesis always occurs in the $5' \rightarrow 3'$ direction.
  • Sigma ($\sigma$) factor: Subunit loosely associated with RNA polymerase that recognizes specific promoter regions. Bacterial cells maintain distinct varieties of $\sigma$ factors that recognize different promoter consensus sequences, allowing rapid transcription of coordinate regulons in response to environmental shifts.
  • Terminator: Distinct nucleotide sequence at which RNA synthesis stops; RNA polymerase detaches from the DNA template and releases the nascent RNA transcript.
  • Stages of Transcription:
  • Initiation: RNA polymerase holoenzyme ($\text{core enzyme} + \sigma\text{ factor}$) binds to the promoter, unwinds and melts a short stretch of double-stranded DNA to expose the template.
  • Elongation: The $\sigma$ factor dissociates from the core enzyme, which moves along the template strand synthesizing complementary single-stranded RNA in the $5' \rightarrow 3'$ direction.
  • Termination: RNA polymerase reaches a terminator sequence, causing the enzyme to stall, dissociate from the template, and release the completed primary RNA transcript.

Bacterial Translation and Protein Synthesis

• The Genetic Code:

  • Information in mRNA is deciphered as non-overlapping triplets of nucleotides designated as codons.
  • Universal Code Properties (Table 7.4):
  • Total of $64$ codons, of which $61$ specify amino acids and $3$ serve as non-coding termination stops.
  • Degeneracy / Redundancy: The genetic code is degenerate; multiple distinct codons specify the same amino acid (e.g., Leucine and Arginine are encoded by six different codons each; Alanine, Valine, Proline, and Threonine are encoded by four codons each).
  • Start Codon: The codon AUG, which encodes Methionine (chemically modified as N-formylmethionine, f-Met, during prokaryotic translation initiation).
  • Stop Codons: The termination codons UAA, UAG, and UGA, which signal the completion of translation and do not encode amino acids.

• Translational Architecture and Machine Components (Table 7.3):

  • Anticodon: Triplet sequence in a transfer RNA (tRNA) molecule complementary to a specific codon in mRNA, enabling the tRNA to recognize and bind the appropriate codon through antiparallel base pairing.
  • mRNA: Single-stranded ribonucleic acid transcript encoding the genetic information deciphered during translation.
  • Reading Frame: The specific grouping of a stretch of nucleotides into sequential non-overlapping triplets. Single-stranded mRNA features three potential reading frames; typically, only one frame represents the correct functional polypeptide.
  • Ribosome: Massive ribonucleoprotein complex coordinating the translation of mRNA into protein polymers.
  • Prokaryotes feature $70S$ ribosomes comprising a small $30S$ subunit and a large $50S$ subunit.
  • Ribosome-Binding Site (Shine-Dalgarno Sequence): A purine-rich nucleotide sequence located upstream on bacterial mRNA to which the small ($30S$) ribosomal subunit binds to orient the start codon.
  • rRNA: Ribosomal RNA species providing both structural scaffolding and catalytic peptidyl transferase activity within ribosomal subunits.
  • Transfer RNA (tRNA): Adaptor molecule folded into a distinct 2D cloverleaf and 3D L-shaped tertiary structure; carries a specific amino acid covalently esterified to its $3'$ CCA acceptor stem and displays a specific anticodon triplet at its opposite loop.

• Stages of Bacterial Translation:
  • Initiation:
  • The $30S$ subunit binds the ribosome-binding site on mRNA and aligns with the initial AUG codon.
  • Initiator tRNA carrying f-Met enters and base-pairs with the start codon, occupying the ribosomal P-site (peptidyl site).
  • The $50S$ large subunit binds, forming the functional $70S$ initiation complex containing three functional sites: the A-site (aminoacyl site), P-site (peptidyl site), and E-site (exit site).
  • Elongation:
  • A charged tRNA with an anticodon matching the codon exposed in the A-site enters and binds.
  • Peptidyl transferase activity (an RNA ribozyme function of the $23S$ rRNA in the $50S$ subunit) breaks the covalent bond between the amino acid and tRNA in the P-site, forming a peptide bond joining it to the amino acid on the tRNA in the A-site.
  • The ribosome translocates exactly three nucleotides ($1$ codon) down the mRNA in the $5' \rightarrow 3'$ direction.
  • The uncharged tRNA moves from the P-site into the E-site and exits the ribosome; the tRNA bearing the nascent polypeptide chain shifts from the A-site into the P-site, vacating the A-site to receive the next charged tRNA.

• Termination:

  • Elongation cycles iterate until a stop codon (UAA, UAG, or UGA) enters the A-site.
  • Stop codons are not recognized by tRNAs; instead, protein release factors bind the A-site and stimulate peptidyl transferase to hydrolyze the ester bond linking the finished polypeptide to the P-site tRNA.
  • The completed polypeptide is released, the mRNA detaches, and the $70S$ ribosome disassembles into its reusable $30S$ and $50S$ subunits.

• Coupled Transcription and Translation:

  • Because prokaryotes lack a nuclear membrane separating the genome from the cytoplasm, translation of nascent mRNA initiates concurrently while the message is still being transcribed by RNA polymerase.

  • Multiple ribosomes bind sequentially to a single mRNA transcript behind RNA polymerase, forming active clusters designated as polyribosomes or polysomes.

  • Post-Translational Polypeptide Processing and Chaperone-Mediated Folding:

• Synthesized polypeptide chains undergo covalent modifications, such as enzymatic cleavage of the initial N-terminal formylmethionine or signal sequence removal.

• Molecular Chaperones: Specialized cellular proteins that assist newly synthesized unfolded or partially misfolded polypeptides in achieving native three-dimensional conformations.

  • Trigger Factor (TF): Binds adjacent to the ribosomal polypeptide exit tunnel to interact with nascent chains immediately upon emergence.
  • DnaK-DnaJ-GrpE Chaperone Machinery: ATP-dependent chaperone team that binds hydrophobic stretches of extended nascent polypeptides, preventing premature misfolding or aggregation.
  • GroEL-GroES Chaperonin Complex: A cylindrical macromolecular barrel into which unfolded polypeptides are encapsulated; utilizes iterative rounds of ATP hydrolysis to fold polypeptides into correct final tertiary conformations.

Comparative Analysis of Prokaryotic and Eukaryotic Molecular Biology

• Major Differences in Transcription and Translation (Table 7.5):
  • mRNA Processing:
  • Prokaryotes: Bacterial mRNA is translated directly in its primary form without covalent end-modifications.
  • Eukaryotes: Primary transcripts (pre-mRNA) undergo extensive co-transcriptional and post-transcriptional processing: addition of a $5'$ methylguanosine cap and polyadenylation of the $3'$ terminus via addition of a $3'$ poly-A tail (conferring transcript stability and facilitating translation export).
  • Gene Structure and Introns:
  • Prokaryotes: Bacterial genes typically lack introns; coding regions are contiguous.
  • Eukaryotes: Genes are interrupted by non-coding sequences (introns) interspersed between coding sequences (exons); precursor transcripts must undergo nuclear splicing via spliceosomes to excise introns and ligate exons.
  • Spatial and Temporal Coupling:
  • Prokaryotes: Transcription and translation occur simultaneously within the same cytoplasmic compartment (coupled gene expression).
  • Eukaryotes: Transcription and RNA processing occur exclusively inside the membrane-bound nucleus; processed mature mRNA must be exported across nuclear pore complexes into the cytoplasm for translation.
  • Cistronic Organization of Transcripts:
  • Prokaryotes: mRNA is frequently polycistronic, encoding multiple distinct functional polypeptides translated independently under the control of a single upstream promoter; translation initiates at internal ribosome-binding sites preceding each start codon.
  • Eukaryotes: mRNA is virtually always monocistronic, encoding a single polypeptide; the $40S$ ribosomal subunit binds the $5'$ cap and scans downstream to locate the initial AUG codon.
  • Ribosomal Structural Differences:
  • Prokaryotes: Possess $70S$ ribosomes constructed from a $30S$ subunit ($16S$ rRNA, 21 proteins) and a $50S$ subunit ($23S$ rRNA, $5S$ rRNA, 31 proteins).
  • Eukaryotes: Cytoplasm features $80S$ ribosomes constructed from a $40S$ subunit ($18S$ rRNA) and a $60S$ subunit ($28S$, $5.8S$, and $5S$ rRNAs).
  • Structural divergence between bacterial $70S$ and eukaryotic $80S$ ribosomes provides the molecular basis for selective toxicity exhibited by clinical ribosome-targeting antibiotics (e.g., aminoglycosides, tetracyclines, macrolides).

Bacterial Mutation and Antibiotic Resistance Evolution

• Mechanisms of Genetic Variation in Bacteria:

  • Bacterial populations acquire genetic diversity via two mechanisms:
  • Spontaneous Mutation: Heritable changes in the existing nucleotide sequence of the cellular genome, propagated vertically to daughter cells during binary fission.
  • Horizontal Gene Transfer (HGT): Acquisition of foreign DNA sequences from an unrelated donor organism.

• Dynamics of Spontaneous Mutations:

  • Mutation Rate: The statistical probability of a mutation occurring per cell division; typically ranges between $10^{-4}$ and $10^{-12}$ per cell division for any given individual bacterial gene.
  • Mutations arise stochastically during normal biological operations due to nucleotide misincorporation during replication or spontaneous chemical modifications (e.g., deamination).
  • Environmental Selection versus Causation:
  • Environmental agents (such as antimicrobial drugs) do not induce targeted protective mutations; the mutations occur randomly prior to exposure.
  • The presence of an antibiotic exerts strong selective pressure, eliminating susceptible cells while permitting mutant organisms harboring resistance to survive and outgrow.
  • Mathematical Basis for Combination Therapy:
  • If the spontaneous mutation frequency conferring resistance to Antibiotic A is $10^{-6}$ and that for Antibiotic B is $10^{-8}$, the simultaneous probability of a single bacterial cell acquiring spontaneous mutations conferring resistance to both antibiotics concurrently is the mathematical product of the independent probabilities:       $10^{-6} \times 10^{-8} = 10^{-14}$
  • Administering two different antibiotic classes simultaneously reduces the emergence of resistant variants in clinical infections.

• Base Substitutions and Point Mutations:

  • Base Substitution: The most frequent category of spontaneous mutation, occurring when DNA polymerase incorporates an incorrect, non-complementary nucleotide during synthesis.
  • Point Mutation: A genetic modification altering a single base pair within double-stranded DNA.
  • Subsequent rounds of DNA replication perpetuate the incorrect base on the template strand, establishing a permanently altered mutant genome in a fraction of the progeny.

• Clinical Case Study: Evolution of Staphylococcus aureus and MRSA:

  • Staphylococcus aureus is a Gram-positive coccal bacterium colonizing human skin and nares, and an opportunistic agent of cutaneous and invasive infections.
  • Emergence of Methicillin Resistance:
  • Introduced in the 1970s, semi-synthetic penicillin derivatives like methicillin served as first-line agents against penicillinase-producing S. aureus.
  • By 2004, over $60\%$ of S. aureus isolates recovered from hospitalized patients demonstrated methicillin resistance.
  • An estimated $2.3\text{ million}$ healthy individuals in the United States harbor methicillin-resistant S. aureus (MRSA) as asymptomatic commensal carriage.
  • Epidemiological Subtypes:
  • Healthcare-Associated MRSA (HA-MRSA): Strains originating within clinical healthcare settings, frequently displaying extensive multi-drug resistance phenotypes.
  • Community-Associated MRSA (CA-MRSA): Strains circulating outside medical institutions, presenting elevated virulence and distinct resistance profiles.
  • Vancomycin as a Drug of Last Resort:
  • Vancomycin (a glycopeptide antibiotic) represents a critical therapy for intractable HA-MRSA infections.
  • Acquisition of resistance determinants threatens vancomycin efficacy, leading to vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA).

Mechanisms of Horizontal Gene Transfer (HGT)

• Overview and Requisite for Replicon Integration (Table 8.3):

  • Horizontal Gene Transfer (HGT): Lateral transmission of genetic material between distinct bacterial cells.
  • Transferred DNA molecules must be part of an autonomous replicon (possessing an origin of replication, such as a plasmid or whole chromosome) to replicate and persist.
  • Linear DNA fragments lacking an origin of replication degrade unless integrated into the recipient cell's circular chromosome via homologous recombination (which requires high sequence similarity with the recipient genome).
  • Mechanisms of Horizontal Gene Transfer:
  • Transformation: Transfer of naked extracellular DNA; transfers approximately 20 genes; sensitive to external DNase degradation.
  • Transduction: DNA transfer enclosed in a bacteriophage coat; transfers a small fraction of the bacterial chromosome; insensitive to external DNase.
  • Conjugation (Plasmid Transfer): Transfer requiring direct physical cell-to-cell contact; transfers an entire plasmid; insensitive to external DNase.
  • Conjugation (Chromosome Transfer): Transfer requiring direct physical cell-to-cell contact; donor must be an Hfr cell; transfers a variable fraction of the chromosome; insensitive to external DNase.

• DNA-Mediated Transformation:

  • The uptake of naked extracellular DNA fragments from the surrounding aqueous environment by competent bacterial cells.
  • Naked DNA: DNA unassociated with proteins or viral coats, released into the environment following autolysis of donor bacteria.
  • Presence of extracellular deoxyribonuclease (DNase) rapidly degrades naked DNA and eliminates transformation completely, serving as an experimental diagnostic.
  • Griffith's Historic Pneumococcal Experiment (1928):
  • Investigated Streptococcus pneumoniae in a murine model:
    • Living encapsulated (smooth) cells injected: Mouse dies; living encapsulated cells isolated.
    • Living non-encapsulated (rough) cells injected: Mouse lives; no bacteria isolated.
    • Heat-killed encapsulated cells injected: Mouse lives; no bacteria isolated.
    • Heat-killed encapsulated cells mixed with living non-encapsulated cells injected: Mouse dies; living encapsulated pathogenic cells isolated.
  • Proved that non-pathogenic rough cells acquired a transforming principle (later identified by Avery, MacLeod, and McCarty as DNA) from heat-killed encapsulated donors, genetically transforming into capsule-producing pathogens.

• Transformation Physiology:

  • Recipient cells must attain a physiological state of competence (tightly regulated via quorum sensing or nutritional cues).

  • Competent cells bind double-stranded naked DNA at cell-surface receptors.

  • One strand is degraded by surface nucleases, while a single intact strand is imported through a membrane pore.

  • The imported single-stranded DNA integrates into the host chromosome via RecA-mediated homologous recombination, displacing the homologous host strand (which is degraded).

  • Transduction:

• Gene transfer mediated by bacterial viruses (bacteriophages).

• Generalized Transduction:

  • Occurs during lytic phage developmental cycles due to a packaging error during virion assembly.
  • Phage-encoded endonucleases fragment host chromosomal DNA.
  • During capsid packaging, a fragment of bacterial chromosomal DNA is mistakenly enclosed inside a phage protein capsid instead of viral nucleic acid, creating a defective transducing particle.
  • When the transducing particle infects a new bacterial recipient host, it injects the donor bacterial DNA.
  • The introduced bacterial DNA incorporates into the recipient chromosome by homologous recombination.
  • Any bacterial chromosomal gene can be transferred via generalized transduction.

• Specialized Transduction:

  • Occurs upon faulty excision of a temperate (lysogenic) prophage from a specific locus within the bacterial chromosome.

  • Only specific bacterial genes immediately flanking the prophage integration attachment site are transferred to the new host.

  • Conjugation:

• DNA transfer mechanism that requires direct physical contact between viable donor and recipient bacterial cells.

• Plasmid Transfer (F Plasmid of E. coli):

  • $F^+$ Donor Cells: Carry the conjugative fertility plasmid (F plasmid) encoding transfer machinery, including the F pilus (sex pilus).
  • $F^-$ Recipient Cells: Lack the F plasmid.
  • The F pilus binds specifically to surface receptors on an $F^-$ recipient cell and retracts, bringing the membranes into contact.
  • A plasmid-encoded relaxase nicks one strand of the F plasmid at the origin of transfer (oriT).
  • A single strand of plasmid DNA is threaded across a mating junction pore into the recipient cell via rolling-circle replication.
  • In both donor and recipient cells, DNA polymerase synthesizes a complementary second strand.
  • Following transfer, both interacting cells are converted into $F^+$ donors capable of synthesizing sex pili.

• Chromosomal DNA Transfer by Hfr Cells:
  • Hfr (High Frequency of Recombination) Cells: Arise when the autonomous circular F plasmid integrates reversibly into the bacterial host chromosome via homologous recombination.
  • When an Hfr cell forms an F pilus and contacts an $F^-$ cell, the integrated plasmid initiates transfer from its internal oriT site.
  • Transfer pulls along adjacent chromosomal genes in linear sequence.
  • Transfer of the entire bacterial chromosome is extremely slow ($\sim 100\text{ minutes}$ for E. coli); normal mechanical agitation breaks the conjugation bridge before completion.
  • The recipient cell receives only partial chromosomal DNA and an incomplete portion of the F plasmid; therefore, the recipient remains an $F^-$ cell while recombining the transferred donor chromosomal alleles.
• Formation of $F'$ (F-Prime) Plasmids:
  • Occurs when the integrated F plasmid in an Hfr strain excises imprecisely from the host chromosome.
  • Carries adjacent host chromosomal DNA sequences along within the circularized plasmid.
  • $F'$ plasmids remain autonomous replicons and can rapidly mobilize host genes into new recipients during conjugation.

The Mobile Gene Pool: Plasmids, Transposons, and Genomic Islands

• Core Genome versus the Mobile Gene Pool:

  • Comparative genomic analyses demonstrate wide intraspecific genomic heterogeneity.
  • Core Genome: The set of genes present in all strains belonging to a given bacterial species; comprises approximately $75\%$ of all genes identified across typical Escherichia coli strains.
  • Mobile Gene Pool (Pan-Genome Components): The remaining variable genomic segments that vary between distinct clinical, environmental, and pathogenic strains.
  • Encompasses plasmids, transposons, genomic islands, and integrated bacteriophage genomes (prophages).

• Plasmids and Plasmid-Coded Traits (Table 8.4 & Table 8.5):

  • Plasmids: Autonomous circular double-stranded DNA replicons replicating independently of the bacterial chromosome.
  • Size varies from a few kilobase pairs ($\text{kbp}$) to several hundred $\text{kbp}$; carry non-essential accessory genes.
  • Copy Number Variation:
  • Low-copy-number plasmids: Maintained at $1\text{ to a few}$ copies per cell.
  • High-copy-number plasmids: Maintained at high abundance, potentially up to $500$ copies per cell.
  • Host Range Distribution:
  • Narrow host range: Capable of replication only within a single bacterial species or closely related genera.
  • Broad host range: Capable of replication and transfer across widely divergent taxa, including between Gram-negative and Gram-positive bacteria.
  • Ecological and Pathological Traits Encoded on Plasmids (Table 8.5):
  • Antibiotic resistance: Widespread across many genera, including Escherichia coli, Salmonella sp., Neisseria sp., Staphylococcus sp., and Shigella sp.
  • Pilus synthesis: Encoded in E. coli and Pseudomonas sp.
  • Tumor formation in plants: Mediated by the Ti plasmid in Agrobacterium sp.
  • Nitrogen fixation: Symbiotic pathways carried in Rhizobium sp.
  • Oil degradation: Hydrocarbon degradation operons in Pseudomonas sp.
  • Gas vacuole production: Buoyancy organelles in halophilic Halobacterium sp.
  • Insect toxin synthesis: Crystal delta-endotoxin genes in Bacillus thuringiensis.
  • Plant hormone synthesis: Auxin/cytokinin generation in Pseudomonas sp.
  • Antibiotic synthesis: Secondary metabolite operons in Streptomyces sp.
  • Increased virulence: Type III secretion and adhesins in Yersinia sp.
  • Toxin production: Anthrax tripartite toxin genes carried on plasmids pXO1 and pXO2 in Bacillus anthracis.

• Resistance Plasmids (R Plasmids):

  • Encode resistance to multiple antimicrobial agents, antiseptics, and toxic heavy metals (mercury, arsenic).
  • Typically structurally divided into two components:
  • R Genes (Resistance Determinants): Encode specific enzymes that degrade or modify antibiotics, activate multi-drug efflux pumps, or modify drug binding targets.
  • Resistance Transfer Factor (RTF): Encodes the complete operon of transfer genes directing conjugative mating and pilus synthesis.
  • Broad host range R plasmids can be transferred conjugatively from benign commensal microbiota to human pathogens in clinical settings.

• Transposable Genetic Elements (Transposons):

  • Segments of DNA capable of moving ("jumping") from one locus to another within a cell's genome via non-homologous recombination.
  • Transposons can transpose between sites on a chromosome, from a chromosome to a plasmid, or between two plasmids.
  • Insertion Sequences (IS):
  • The simplest transposable elements.
  • Contain a central gene encoding transposase (the enzyme that cleaves and integrates the element) flanked on both sides by identical or inverted short repeat sequences.
  • Composite Transposons:
  • Larger transposable units constructed from two flanking insertion sequences bounding one or more internal structural genes (such as antibiotic resistance determinants).
  • Role in Clinical Resistance Emergence (The VRSA Paradigm):
  • Documented in clinical patients co-infected with methicillin-resistant Staphylococcus aureus (susceptible to vancomycin) and vancomycin-resistant Enterococcus faecalis (VRE).
  • E. faecalis transferred a conjugative plasmid to S. aureus via conjugation.
  • A composite transposon carrying the vanA vancomycin-resistance gene jumped from the enterococcal plasmid into a resident S. aureus plasmid.
  • Even after the foreign enterococcal plasmid was cleared, the resident staphylococcal plasmid retained the vancomycin-resistance transposon, creating vancomycin-resistant Staphylococcus aureus (VRSA).

Bacterial Immune Defenses Against Foreign Genetic Elements

• Restriction-Modification (R-M) Systems:
  • An innate enzymatic defense system that degrades foreign DNA (such as invading bacteriophage genomes or foreign plasmids).
  • Operates via coordinated activity of two enzymes:
  • Restriction Endonuclease: Recognizes specific short palindromic nucleotide sequences in double-stranded DNA and cleaves phosphodiester bonds on both strands.
  • Modification Methyltransferase: Chemically modifies the cell's own endogenous chromosomal DNA by adding methyl groups ($-\text{CH}_3$) to specific adenines or cytosines within identical recognition sequences, protecting host DNA from endonuclease digestion.
  • When unmethylated bacteriophage DNA enters the bacterium, the restriction endonuclease recognizes the unmethylated sites and cleaves the viral genome, preventing infection.
  • If the foreign DNA is accidentally methylated by host methyltransferases before the restriction enzyme cleaves it, the phage genome replicates, and progeny phages emerge bearing host-specific methylation patterns.

• CRISPR-Cas Systems (Clustered Regularly Interspaced Short Palindromic Repeats):
  • An adaptive, sequence-specific immune mechanism providing acquired resistance against bacteriophages and mobile genetic elements.
  • CRISPR Array Architecture:
  • Locus composed of clusters of identical conserved short palindromic repeat sequences separated by unique variable sequences termed spacers.
  • Each unique spacer sequence corresponds to a fragment of foreign DNA captured from an invading genetic element during prior infections.
  • Flanked upstream by an operon of Cas (CRISPR-associated) genes encoding endonucleases and helicases.

• Three-Step Mechanism of CRISPR-Cas Immunity:
  • Step 1: Adaptation (Spacer Acquisition): Upon initial invasion by an unencountered bacteriophage, a protein complex composed of Cas nucleases recognizes and fragments the foreign viral DNA, inserting a piece of it as a novel spacer into the upstream end of the chromosomal CRISPR array.
  • Step 2: Biogenesis (crRNA Processing): The entire CRISPR array is transcribed into a long primary precursor RNA transcript. Cas endonucleases process this precursor, cleaving it within repeat sequences into short CRISPR RNAs (crRNAs), each containing one spacer sequence attached to a repeat hairpin.
  • Step 3: Interference (Target Destruction): Each crRNA binds to a Cas endonuclease (e.g., Cas9) to assemble a functional surveillance ribonucleoprotein complex. If a bacteriophage carrying a sequence identical to the spacer invades again, the crRNA base-pairs with the complementary foreign DNA, guiding the Cas nuclease to introduce lethal double-stranded breaks that destroy the invading genome.